Trial Profile
Risk of hospitalized infection in patients with rheumatoid arthritis who treated with abatacept and other biologics
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Aug 2016
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- 29 Aug 2016 New trial record